EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic variants predisposing to an increased risk of kidney stone disease

Catherine E Lovegrove, Michelle Goldsworthy, Jeremy Haley, Diane Smelser, Caroline Gorvin, Fadil M Hannan, Anubha Mahajan, Mohnish Suri, Omid Sadeghi-Alavijeh, Shabbir H Moochhala, Daniel P Gale, David Carey und 4 weitere

Journal of Clinical Investigation · 01.08.2025 · 135 (15)

DOI: 10.1172/jci186915 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.05.2025. Verfasst von Catherine E Lovegrove und 15 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Kidney Calculi, Genetic Predisposition to Disease. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, OHSRC, Kidney Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Kidney stone disease (KSD) affects approximately 10% of adults, is heritable, and is associated with mineral metabolic abnormalities. METHODS Genetic variants and pathways increasing KSD risk via calcium and phosphate homeostasis were ascertained using GWAS, region-specific Mendelian randomization (MR), and genetic colocalization. The utility of pathway modulation was estimated via drug target MR, and the effects of variants on calcium-sensing receptor (CaSR) signaling were characterized. RESULTS Seventy-nine independent KSD-associated genetic signals at 71 loci were identified. MR identified 3 loci affecting KSD risk via increased serum calcium or decreased serum phosphate concentrations (ORs for genomic regions = 4.30, 11.42, and 13.83 per 1 SD alteration; P < 5.6 × 10 –10 ). Colocalization analyses defined putative, noncoding KSD-causing variants estimated to account for 11%–19% of KSD cases in proximity to diacylglycerol kinase δ ( DGKD ), a CaSR signaling partner; solute carrier family 34 member 1 ( SLC34A1 ), a renal sodium-phosphate transporter; and cytochrome P450 family 24 subfamily A member 1 ( CYP24A1 ) , which degrades 1,25-dihydroxyvitamin D. Drug target MR indicated that reducing serum calcium by 0.08 mmol/L via CASR , DGKD , or CYP24A1 , or increasing serum phosphate by 0.16 mmol/L via SLC34A1 may reduce KSD relative risk by up to 90%. Furthermore, reduced DGKδ expression and KSD-associated DGKD missense variants impaired CaSR signal transduction in vitro, which was ameliorated by cinacalcet, a positive CaSR allosteric modulator. CONCLUSION DGKD -, SLC34A1 -, and CYP24A1 -associated variants linked to reduced CaSR signal transduction, increased urinary phosphate excretion, and impaired 1,25-dihydroxyvitamin D inactivation, respectively, are common causes of KSD. Genotyping patients with KSD may facilitate personalized KSD risk stratification and targeted pharmacomodulation of associated pathways to prevent KSD. FUNDING Oxfordshire Health Services Research Committee (OHSRC, part of Oxford Hospitals Charity); Kidney Research UK (RP_030_20180306); The Urology Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (NF-SI-0514–10091); Wellcome Trust (204826/z/16/z and 106995/z/15/z); Medical Research Council (MRC) Clinical Research Training Fellowships (MR/W03168X/1 and MR/S021329/1); Wellcome Trust Clinical Career Development Fellowship; Sir Henry Dale Fellowship, with joint funding by the Wellcome Trust and the Royal Society (224155/Z/21/Z); St. Peter’s Trust for Kidney Bladder and Prostate Research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney CalculiGenetic Predisposition to DiseaseHumansReceptors, Calcium-SensingMaleGenome-Wide Association StudyFemalePhosphatesAdultMendelian Randomization AnalysisCalciumSodium-Phosphate Cotransporter Proteins, Type IIaSignal TransductionMiddle Aged

Stichwörter der Autor:innen

Calcium signalingEndocrinologyGenetic variationGeneticsNephrologyUrology

Substanzen

Receptors, Calcium-SensingPhosphatesSLC34A1 protein, humanCalciumCASR protein, humanSodium-Phosphate Cotransporter Proteins, Type IIa

Autor:innen und Institutionen

  • Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
  • Department of Genomic Health, Geisinger Medical Center, Danville, Pennsylvania, USA.
  • Institute of Metabolism and Systems Research and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, United Kingdom.
  • Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom, USA.
  • UCL Department of Renal Medicine, University College London, London, United Kindom.

Förderung

  • Wellcome Trust
  • OHSRC
  • Kidney Research UK
  • The Urology Foundation
  • National Institute for Health Research (N.I.H.R) Oxford Biomedical Research Centre
  • Medical Research Council
  • St Peter’s Trust for Kidney Bladder and Prostate Research
  • Wellcome Trust and the Royal Society

Zitieren

APA

Lovegrove, C. E., Goldsworthy, M., Haley, J., Smelser, D., Gorvin, C., Hannan, F. M., Mahajan, A., Suri, M., Sadeghi-Alavijeh, O., Moochhala, S. H., Gale, D. P., Carey, D., Holmes, M. V., Furniss, D., Thakker, R. V., & Howles, S. A. (2025). Genetic variants predisposing to an increased risk of kidney stone disease. Journal of Clinical Investigation, 135(15). https://doi.org/10.1172/jci186915

Vancouver

Lovegrove CE, Goldsworthy M, Haley J, Smelser D, Gorvin C, Hannan FM, et al. Genetic variants predisposing to an increased risk of kidney stone disease. Journal of Clinical Investigation. 2025;135(15). doi:10.1172/jci186915

BibTeX
@article{Lovegrove2025,
  author = {Lovegrove, Catherine E and Goldsworthy, Michelle and Haley, Jeremy and Smelser, Diane and Gorvin, Caroline and Hannan, Fadil M and Mahajan, Anubha and Suri, Mohnish and Sadeghi-Alavijeh, Omid and Moochhala, Shabbir H and Gale, Daniel P and Carey, David and Holmes, Michael V and Furniss, Dominic and Thakker, Rajesh V and Howles, Sarah A},
  title = {Genetic variants predisposing to an increased risk of kidney stone disease},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {15},
  doi = {10.1172/jci186915}
}
Kostenlos starten →